論文

査読有り
2013年

Differences in dose-volumetric data between the analytical anisotropic algorithm and the x-ray voxel Monte Carlo algorithm in stereotactic body radiation therapy for lung cancer

Medical Dosimetry
  • Wambaka Ange Mampuya
  • ,
  • Yukinori Matsuo
  • ,
  • Akira Nakamura
  • ,
  • Mitsuhiro Nakamura
  • ,
  • Nobutaka Mukumoto
  • ,
  • Yuki Miyabe
  • ,
  • Masaru Narabayashi
  • ,
  • Katsuyuki Sakanaka
  • ,
  • Takashi Mizowaki
  • ,
  • Masahiro Hiraoka

38
1
開始ページ
95
終了ページ
99
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1016/j.meddos.2012.07.007

The objective of this study was to evaluate the differences in dose-volumetric data obtained using the analytical anisotropic algorithm (AAA) vs the x-ray voxel Monte Carlo (XVMC) algorithm for stereotactic body radiation therapy (SBRT) for lung cancer. Dose-volumetric data from 20 patients treated with SBRT for solitary lung cancer generated using the iPlan XVMC for the Novalis system consisting of a 6-MV linear accelerator and micro-multileaf collimators were recalculated with the AAA in Eclipse using the same monitor units and identical beam setup. The mean isocenter dose was 100.2% and 98.7% of the prescribed dose according to XVMC and AAA, respectively. Mean values of the maximal dose (Dmax), the minimal dose (Dmin), and dose received by 95% volume (D95) for the planning target volume (PTV) with XVMC were 104.3%, 75.1%, and 86.2%, respectively. When recalculated with the AAA, those values were 100.8%, 77.1%, and 85.4%, respectively. Mean dose parameter values considered for the normal lung, namely the mean lung dose, V5, and V20, were 3.7Gy, 19.4%, and 5.0% for XVMC and 3.6Gy, 18.35, and 4.7% for the AAA, respectively. All of these dose-volumetric differences between the 2 algorithms were within 5% of the prescribed dose. The effect of PTV size and tumor location, respectively, on the differences in dose parameters for the PTV between the AAA and XVMC was evaluated. A significant effect of the PTV on the difference in D95 between the AAA and XVMC was observed (p = 0.03). Differences in the marginal doses, namely Dmin and D95, were statistically significant between peripherally and centrally located tumors (p = 0.04 and p = 0.02, respectively). Tumor location and volume might have an effect on the differences in dose-volumetric parameters. The differences between AAA and XVMC were considered to be within an acceptable range (&lt
5 percentage points). © 2012 American Association of Medical Dosimetrists.

リンク情報
DOI
https://doi.org/10.1016/j.meddos.2012.07.007
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/23246194
ID情報
  • DOI : 10.1016/j.meddos.2012.07.007
  • ISSN : 0958-3947
  • ISSN : 1873-4022
  • PubMed ID : 23246194
  • SCOPUS ID : 84873135070

エクスポート
BibTeX RIS